イベルメクチンが死亡リスクを92％減少させるという新しい研究結果

A new peer-reviewed study from Brazil has found that Ivermectin, an anti-patristic drug that some like Joe Rogan advocated for to treat Covid-19, has been found to reduce the risk of dying from the coronavirus by 92 percent.

The study was conducted in Itajai, Brazil by lávio A. Cadegiani, MD, MSc, Ph.D., who is an expert on clinical endocrinology, according to Blaze News.

“Among 223,128 subjects from the city of Itajaí, 159,560 were 18 years old or up and were not infected by COVID-19 until July 7, 2020, from which 45,716 (28.7%) did not use and 113,844 (71.3%) used ivermectin,” the study explained. “Among ivermectin users, 33,971 (29.8%) used irregularly (up to 60 mg) and 8,325 (7.3%) used regularly (more than 180 mg). The remaining 71,548 participants were not included in the analysis.”

Amongst the subjects who used Ivermectin before being infected, they experienced reductions in both death and hospitalizations: “The hospitalization rate was reduced by 100% in regular users compared to both irregular users and non-users.”

92 percent of those who took Ivermectin regularly saw a 92 percent reduction in their death risk compared to non-users and an 84 percent death risk reduction compared to irregular users.

北里研究所　花木教授

厚労省の診療の手引きの内容について

『研究者はイベルメクチンを有効だと報告した。しかし論文をまとめた人は無効であるとした。要するに数字の入れ替えをおこなった。このデータをもって厚労省の公的な文書に載せるなんて考えられない』
pic.twitter.com/b9lREFj34Q

— ヒカル　イベルメクチン服用体験 (@hikaru1032) August 19, 2022